Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16004883rdf:typepubmed:Citationlld:pubmed
pubmed-article:16004883lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16004883lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:16004883lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:16004883lifeskim:mentionsumls-concept:C0054836lld:lifeskim
pubmed-article:16004883lifeskim:mentionsumls-concept:C0340288lld:lifeskim
pubmed-article:16004883lifeskim:mentionsumls-concept:C1158882lld:lifeskim
pubmed-article:16004883pubmed:issue3lld:pubmed
pubmed-article:16004883pubmed:dateCreated2005-7-11lld:pubmed
pubmed-article:16004883pubmed:abstractTextNeutrophil superoxide anion (O(2)(*-)) generation was measured during carvedilol therapy in patients with stable angina. The carvedilol group comprised 27 patients (18 men and 9 women), aged 38-51 years (mean 47.6 years) with stable angina. Carvedilol was administered in increased every 4-week doses: 12.5, 25 and 50 mg/24 h, respectively. The control group included 12 healthy subjects, aged 39-49 years (mean 45.7 years) with no drug administered. Blood samples were collected from cubital vein before and 4, 8 and 12 weeks after the therapy and once in the control group. Neutrophil O(2)(*-) generation was determined in whole blood without and with opsonized zymosan (OZ) stimulation according to Bellavite et al. method using superoxide dismutase from bovine erythrocytes. O(2)(*-) generation by nonstimulated and OZ-stimulated neutrophils was significantly higher (p<0.05) in patients with stable angina than in the control group. In carvedilol group, statistically significant (p<0.05) decrease in superoxide anion generation by nonstimulated and OZ-stimulated neutrophils was observed 8 and 12 weeks after the therapy and it did not differ from that in healthy subjects. Carvedilol has been shown to inhibit neutrophil O(2)(*-) generation in patients with stable angina.lld:pubmed
pubmed-article:16004883pubmed:languageenglld:pubmed
pubmed-article:16004883pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16004883pubmed:citationSubsetIMlld:pubmed
pubmed-article:16004883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16004883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16004883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16004883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16004883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16004883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16004883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16004883pubmed:statusMEDLINElld:pubmed
pubmed-article:16004883pubmed:monthJullld:pubmed
pubmed-article:16004883pubmed:issn0167-5273lld:pubmed
pubmed-article:16004883pubmed:authorpubmed-author:B?aszczykJanJlld:pubmed
pubmed-article:16004883pubmed:authorpubmed-author:KowalskiJanJlld:pubmed
pubmed-article:16004883pubmed:authorpubmed-author:KowalczykEdwa...lld:pubmed
pubmed-article:16004883pubmed:authorpubmed-author:PeteckaEdytaElld:pubmed
pubmed-article:16004883pubmed:authorpubmed-author:PawlickiLucja...lld:pubmed
pubmed-article:16004883pubmed:authorpubmed-author:Irzma?skiRobe...lld:pubmed
pubmed-article:16004883pubmed:authorpubmed-author:Cegli?skiToma...lld:pubmed
pubmed-article:16004883pubmed:authorpubmed-author:KowalskaEwaElld:pubmed
pubmed-article:16004883pubmed:issnTypePrintlld:pubmed
pubmed-article:16004883pubmed:day20lld:pubmed
pubmed-article:16004883pubmed:volume102lld:pubmed
pubmed-article:16004883pubmed:ownerNLMlld:pubmed
pubmed-article:16004883pubmed:authorsCompleteYlld:pubmed
pubmed-article:16004883pubmed:pagination397-402lld:pubmed
pubmed-article:16004883pubmed:dateRevised2006-7-12lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:meshHeadingpubmed-meshheading:16004883...lld:pubmed
pubmed-article:16004883pubmed:year2005lld:pubmed
pubmed-article:16004883pubmed:articleTitleNeutrophils superoxide anion generation during carvedilol therapy in patients with stable angina.lld:pubmed
pubmed-article:16004883pubmed:affiliationDepartment of Internal Medicine and Cardiological Rehabilitation, Medical University of ?ód?, Poland.lld:pubmed
pubmed-article:16004883pubmed:publicationTypeJournal Articlelld:pubmed